A randomized, double-blind, active-control trial to evaluate the efficacy and safety of a three day course of tafenoquine monotherapy for the treatment of Plasmodium vivax malaria
Keyword(s):
Keyword(s):
2020 ◽
Vol 103
(3)
◽
pp. 1088-1093
Keyword(s):
2005 ◽
Vol 73
(5)
◽
pp. 842-849
◽
Keyword(s):
2018 ◽
Vol 67
(10)
◽
pp. 1543-1549
◽
Keyword(s):
Keyword(s):
Keyword(s):
2005 ◽
Vol 73
(6)
◽
pp. 1108-1111
◽
Keyword(s):